drugset / Trial / NCT01248338

Effects of Nebivolol Versus Metoprolol Succinate on Endothelial Function

NCT01248338

Phase 4 Completed 80 enrolled Berlin-Chemie Menarini
RandomizedParallel-groupQuadruple-blindTreatment

Summary

An impairment of endothelial function plays the central role in the pathogenesis of cardiovascular diseases and their complications. Most of cardiovascular risk factors are known to impair endothelial function and the established disease further aggravates endothelial dysfunction. The aim of the present study is to investigate the effects of nebivolol or metoprolol succinate on endothelial function and large artery stiffness.

Timeline

Start
2006-03
Primary completion
2008-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol Other / unclassified 50 mg Oral
Comparator Metoprolol Other / unclassified 100 mg Oral
Subject Nebivolol Other / unclassified 5 mg

Indications